Regenxbio (RGNX) Research & Development (2016 - 2025)
Historic Research & Development for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $56.1 million.
- Regenxbio's Research & Development rose 307.19% to $56.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.1 million, marking a year-over-year increase of 245.3%. This contributed to the annual value of $208.5 million for FY2024, which is 1022.28% down from last year.
- Per Regenxbio's latest filing, its Research & Development stood at $56.1 million for Q3 2025, which was up 307.19% from $59.5 million recorded in Q2 2025.
- Regenxbio's 5-year Research & Development high stood at $63.3 million for Q3 2022, and its period low was $39.7 million during Q1 2021.
- Moreover, its 5-year median value for Research & Development was $55.6 million (2022), whereas its average is $54.4 million.
- Per our database at Business Quant, Regenxbio's Research & Development soared by 4004.08% in 2022 and then plummeted by 1839.66% in 2024.
- Over the past 5 years, Regenxbio's Research & Development (Quarter) stood at $48.0 million in 2021, then surged by 30.28% to $62.5 million in 2022, then dropped by 10.92% to $55.7 million in 2023, then fell by 9.52% to $50.4 million in 2024, then grew by 11.36% to $56.1 million in 2025.
- Its Research & Development stands at $56.1 million for Q3 2025, versus $59.5 million for Q2 2025 and $53.1 million for Q1 2025.